Ventas (VTR)
Real Estate · Healthcare REITs · NYSE
Ventas is a leading healthcare REIT delivering value through a massive portfolio of senior housing, research, and outpatient medical facilities serving an aging population.
What Ventas does
Ventas is a real estate investment trust (REIT) that owns and operates a diversified portfolio of senior housing communities, outpatient medical buildings, research centers, and healthcare facilities. The company operates through three primary segments: Senior Housing Operating Portfolio (SHOP), Outpatient Medical and Research (OM&R), and triple-net leased (NNN) properties. Ventas also manages a private capital investment platform, Ventas Investment Management (VIM), which partners with institutional investors.
Themes: senior housing, healthcare real estate, life sciences infrastructure, aging population demographics, real estate investment trusts (REITs)
Fundamentals
- Price$93.47 as of 2026-08-24 close
- Market cap$47.9B as of 2026-08-24
- 1-year return+37.9% 2025-08-22 close $67.79 → 2026-08-24 close $93.47
- P/E173.78 as of 2026-08-25
- Net margin+4.1% as of 2026-08-25
- Gross margin+40.2% as of 2026-08-25
- ROE+1.9% as of 2026-08-25
- Debt / equity0.84 as of 2026-08-25
- Revenue growth (YoY)+21.5% as of 2026-08-25
- Revenue CAGR (3y)+12.2% SEC XBRL
- Beta0.74 as of 2026-08-25
- Last reported earnings2026-07-29 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +2.3%; at least 5 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How VTR compares in its sector
- price-to-earnings ratiotop 10% 127 covered Real Estate peers, as of 2026-08-25
- net profit marginmiddle range 161 covered Real Estate peers, as of 2026-08-25
- operating marginmiddle range 161 covered Real Estate peers, as of 2026-08-25
- gross marginbottom 25% 156 covered Real Estate peers, as of 2026-08-25
- return on equitymiddle range 162 covered Real Estate peers, as of 2026-08-25
- 3-year revenue CAGRtop 25% 155 covered Real Estate peers
- indicated dividend yieldbottom 25% 138 covered Real Estate peers, as of 2026-08-25
- free cash flow (absolute dollars, latest fiscal year)bottom 10% 42 covered Real Estate peers, as of FY2025
Position among covered Real Estate companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
VTR is not currently in any published Top 10 list. Its scores are below.
Long-term score
56.0 #458 of 1,605 scored · #26 of 95 in Real Estate
Capital return 80th (consecutive years of dividend increases 5 years) and growth 74th (revenue growth year over year 21.5%, 3-year revenue CAGR 12.2%); weakest is valuation (28th, price to earnings 171.5, price to book 3.3).
Short-term score
53.1 #510 of 1,698 scored · #20 of 95 in Real Estate
Trend 66th: a "golden cross" — its 50-day average is above its 200-day; volume and participation 65th: it gapped 6.9% above the previous close and has not traded back through the level it left behind — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed; weakest is setup 36th: no fresh 20-day breakout up or down.
Scores as of 24 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 3.
Dividend coverage (FY2025)
Not assessable from available data. VTR paid a dividend in FY2025, but coverage cannot be assessed from the available data (net_income_unavailable, non_positive_free_cash_flow).
- Earnings payoutnot assessable earnings not reported
- Free-cash-flow payoutnot assessable free cash flow was not positive that year
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How Ventas looks technically
Ventas (VTR) is trading 10.8% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 272 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 20, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 54, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 1 trading day ago (its momentum flipped positive). It made a new 20-day low about 10 trading days ago.
Trend
7
| Distance from the 200-day | it is trading 10.8% above its 200-day average, the long-term trend line — a longer-term uptrend | +10.8% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $91.41 | $91.41 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $84.38 | $84.38 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing low 13 calendar days ago — the swings before that are what the structure reading is measured on | 13 sessions |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 272 trading days ago — a "golden cross", a bullish long-term signal | 272 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 20, below the 25 that marks a real trend) | 19.8 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 54, neither overbought (above 70) nor oversold (below 30) | 54.2 |
|---|---|---|
| Position in its 14-day range | it is trading near the top of its 14-day range ($86.93 to $94.42) — its "stochastic" reading is 87 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 87.3 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 1 trading day ago (its momentum flipped positive) | 1 session |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $101.60 | $101.60 |
|---|---|---|
| From the 52-week high | it is 8.0% below its 52-week high (its highest price of the past year) | -8.0% |
| Above the 52-week low | it is 40.8% above its 52-week low (its lowest price of the past year) | +40.8% |
| Below the 52-week high | it is 8.0% below its highest point of the past year | 8.0% |
| Since a 20-day breakout | it made a new 20-day low about 10 trading days ago | 10 sessions |
| Since a 55-day breakout | it made a new 55-day high about 22 trading days ago | 22 sessions |
| All-time high | its highest closing price on record is $101.60 (set on 2026-07-28) | $101.60 |
| Given back of the 52-week move | over the past year its closes ranged ($67.13 to $100.53), and it has given back roughly a quarter of its rise from last year’s low — 21% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $78.82 to $79.89. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 21.1% |
| From the all-time high | it is 8.0% below its all-time high | -8.0% |
| Nearest price level | it is trading 6.3% above a support level at $87.60 — a price it turned at four times since 2026-02-17, most recently on 2026-08-11. Since 2024-08-26 it has 11 such levels below the current price and 0 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -6.3% |
| All-time low | its lowest closing price on record is $13.35 (set on 2020-03-18) | $13.35 |
| Above the all-time low | it is 600.4% above its all-time low | +600.4% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 44th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $2.12 between its high and its low — about 2.3% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $2.12 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $87.33 and $97.10 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $87.33 – $92.22 – $97.10 |
| Typical daily range (% of price) | its price moves about 2.3% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.3% |
| Stretch from the 200-day average | it is trading 4.3 daily ranges above its 200-day average price (10.8% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 4.3 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.75× |
|---|
Analyst
2
| Change in the average price target | analysts have cut their average price target by 0.2% since the prior reading | -0.2% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a doji | today it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | today |
|---|
Price gaps
2
| Gap at the open | it opened on 2026-08-24 0.4% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.4% |
|---|---|---|
| Open gap | it gapped 6.9% above the previous close 50 sessions ago and has not traded back through the level it left behind at 79.62 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +6.9% |
Price streaks
1
| Closing streak | it has closed higher 5 sessions in a row, a +2.52% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 5 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 10.3 percentage points (the stock lost 7.0% while the market gained 3.3%) | -10.3% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 3.6 percentage points (the stock gained 6.0% while the market gained 2.4%) | +3.6% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 2.9 percentage points (the stock gained 8.1% while the market gained 11.1%) | -2.9% |
| vs market, 12 months | over the past 12 months this stock beat the market by 19.6 percentage points (the stock gained 37.9% while the market gained 18.3%) | +19.6% |
Signal agreement
2
| Bullish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, MACD momentum is positive, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 4 of 9 |
|---|---|---|
| Bearish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bearish state: lagging the market over 6 months, near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 2 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 3.1% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-17 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is moderate, spanning 3.3% of the share price. | +3.1% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 9% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $86.03 — a volume-weighted average of daily closes over 159 sessions, not a true tick-by-tick VWAP. | +8.7% |
|---|---|---|
| Vs the average paid since it last reported | the price is 2% above the average price paid since it last reported on 2026-07-29 (its 8-K), so the typical buyer over that stretch is showing a gain. That average is $91.63 — a volume-weighted average of daily closes over 19 sessions, not a true tick-by-tick VWAP. | +2.0% |
Price levels it has turned at before
VTR last closed at $93.47 on 2026-08-24. Since 2024-08-26 it has turned at 11 prices below its last close and 0 above; the 3 nearest below are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $87.60 | Support | 6.3% below the last close | turned there four times · 2026-02-17 to 2026-08-11 |
| $85.60 | Support | 8.4% below the last close | turned there four times · 2026-04-09 to 2026-06-11 |
| $80.55 | Support | 13.8% below the last close | turned there three times · 2025-12-29 to 2026-06-22 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.
Read from daily closes as of 2026-08-24.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · MACD just crossed bullish (12/26/9) · trendless / choppy (low ADX) · Printed a doji candle · On a winning streak (5+ higher closes in a row) · At the top of its 14-day range (stochastic above 80) | Learn: moving average · golden cross · adx · rsi · macd · breakout
Based on daily closing prices as of 2026-08-24. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (1.61 mean, 1=Strong Buy…5=Strong Sell) — 22 analysts
- Mean price target$100.45 range $86.00 – $113.00; median $100.50
Analyst estimates, as of 2026-08-18. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for VTR
- Consensus EPS estimate$0.12 next reporting period, as of 2026-08-18
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Dependence on the financial performance of senior housing operators and healthcare industry trends","Risks associated with maintaining status as a REIT under the Internal Revenue Code","Sensitivity to interest rate fluctuations and capital market conditions impacting real estate valuation and financing"]
What changed in the latest 10-Q
AI-assisted comparison of VTR's 10-Q filed 2026-04-28 against the prior one filed 2025-10-30.
Management's Discussion & Analysis (MD&A)
- Added:
- Added 'artificial intelligence' to list of regulatory areas in factor (a) (filed 2026-04-28)
- Added reference to 'Management's Discussion and Analysis of Financial Condition and Results of Operations' section in the risk disclosure references (filed 2025-10-30 only)
- Removed:
- Removed 'and fiscal policy' from factor (b) macroeconomic description (present in 2025-10-30, absent in 2026-04-28)
- Removed 'our occupancy rates and resident fee revenues' from factor (b) impacts (present in 2025-10-30, absent in 2026-04-28)
- Removed reference to 'Management's Discussion and Analysis of Financial Condition and Results of Operations' from risk disclosure section references (present in 2025-10-30, absent in 2026-04-28)
- Reworded:
- Factor organization restructured: Multiple factors reordered and renumbered between filings
- Changed 'rent from' to 'lease from' in factor discussing third-party manager/tenant reliance (filed 2026-04-28)
- Factor (b) in 2026-04-28 now reads 'general economic conditions' instead of 'general economic conditions and fiscal policy'
- Factor (c) in 2026-04-28 (potential claims/legal actions) was previously factor (c) in 2025-10-30
- Added comprehensive new factors in 2026-04-28: factor (d) on acquisitions/synergies, (e) on identifying investments, (f) on navigating trends, (g) on bankruptcy risk, (h) on capital markets reliance, (i) on limited manager/tenant concentration, (j) on operational risks, (k) on asset class risks, (l) on international operations, (m) on lease/management renewal risks, (n) on borrower default risks, (o) on credit losses/impairments, (p) on unknown liabilities, (q) on M&A activity
- Text appears truncated in both versions at end of provided excerpts, limiting full comparison of all content
- Notes:
- The provided text is truncated at the end of both filings, preventing complete comparison of the full factors listed
- The older filing shows 32 as page number, newer shows 27, suggesting different document lengths or formatting
- Factor reorganization and renumbering makes line-by-line comparison challenging; factors appear reordered rather than purely added/removed
Risk Factors
The two filings could not be meaningfully compared for this section.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
1 open-market purchase and 0 open-market sales by insiders in the last 90 days.
- Last 90 days1 buy ($197025) · 0 sells — 1 buying insider
- Last 180 days1 buy ($197025) · 1 sell ($103915) — 1 buying, 1 selling insiders
Activity heuristic: net buying (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-06-03. As of 2026-08-25.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about VTR's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Congressional trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 2 matched disclosures for VTR from U.S. House Clerk Periodic Transaction Report filings.
Congressional trading disclosures →Short interest (FINRA)
VTR had 23,665,480 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
VTR had 4.61% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 6.46 days to cover at the same settlement.
- Reported short interest (shares) 23,665,480
- Short interest (% of shares outstanding) 4.61%
- Prior settlement (shares) 24,736,618
- Reported change -4.33%
- Days to cover (reported) 6.46
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Welltower (WELL)
- Healthpeak Properties
- Omega Healthcare Investors (OHI)
- Medical Properties Trust
- Sabra Health Care REIT (SBRA)
- Healthcare Realty Trust (HR)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare VTR vs…
Ventas is found in…
Frequently asked questions
What does Ventas (VTR) do?
Ventas is a real estate investment trust (REIT) that owns and operates a diversified portfolio of senior housing communities, outpatient medical buildings, research centers, and healthcare facilities. The company operates through three primary segments: Senior Housing Operating Portfolio (SHOP), Outpatient Medical and Research (OM&R), and triple-net leased (NNN) properties.
What sector is Ventas (VTR) in?
Ventas (VTR) is classified in the Real Estate sector. Its industry is Healthcare REITs. It trades on NYSE.
Does VTR pay a dividend?
Yes — Ventas (VTR) pays a dividend, with an indicated yield of about 2.26% and at least 5 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-08-25). Informational only — not financial advice.
Who are Ventas's (VTR) competitors?
Notable peers of Ventas (VTR) include Welltower, Healthpeak Properties, Omega Healthcare Investors, Medical Properties Trust and Sabra Health Care REIT. This peer set is informational only — not financial advice.
Has there been recent Congressional stock trading in VTR?
Yes — we hold 2 matched STOCK Act disclosures for VTR from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is Ventas (VTR) overbought or oversold right now?
Ventas (VTR) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 54, in the neutral middle (as of 2026-08-24). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on VTR come from?
Fundamentals and prices come from market data, as of 2026-08-25; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-25. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-24.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.